Patient perspectives on incretin-based weight loss medications and relationship with demographic factors.
Megan A McVayWendy S MooreFrancesca L WilkinsJalen R JacksonMichael D RobinsonPublished in: Obesity science & practice (2024)
Demographic considerations, notably education level, should be factored into the strategy to promote equitable utilization of incretin-based therapies, particularly as their accessibility expands.